Cargando…
Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
Predicting the prognosis of patients in advance is conducive to providing personalized treatment for patients. Our aim was to predict the therapeutic efficacy and progression free survival (PFS) of patients with liver metastasis of colorectal cancer according to the changes of computed tomography (C...
Autores principales: | Ye, Shuai, Han, Yu, Pan, XiMin, Niu, KeXin, Liao, YuTing, Meng, XiaoChun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184515/ https://www.ncbi.nlm.nih.gov/pubmed/35692757 http://dx.doi.org/10.3389/fonc.2022.843991 |
Ejemplares similares
-
Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023) -
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases
por: Giannini, Valentina, et al.
Publicado: (2022) -
Radiomics Analysis of Multiparametric MRI for Prediction of Synchronous Lung Metastases in Osteosarcoma
por: Luo, Zhendong, et al.
Publicado: (2022) -
Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC
por: Chen, Lu, et al.
Publicado: (2022) -
A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
por: Lin, Peng, et al.
Publicado: (2020)